State Street Portfolio holdings
State Street Corporation, established in 1792 and headquartered in Boston, Massachusetts, is one of the oldest financial institutions in the United States and a major player in the global asset management and custody banking sectors. Primarily known for its custodial services, it safeguards assets for institutional investors, managing trillions of dollars through its State Street Global Advisors (SSGA) division, which is renowned for launching the first U.S. exchange-traded fund (ETF), the SPDR S&P 500 ETF (SPY), in 1993. The company provides a range of services including investment management, research, trading, and data analytics, catering mostly to institutional clients like pension funds, endowments, and mutual funds. With a focus on financial infrastructure and innovation, State Street has positioned itself as a key backbone in the global investment ecosystem.
Top Buys
| 1 |
DoorDash
DASH
|
+$1.15B |
| 2 |
Amazon
AMZN
|
+$775M |
| 3 |
Charles Schwab
SCHW
|
+$665M |
| 4 |
Verizon
VZ
|
+$637M |
| 5 |
Visa
V
|
+$525M |
Top Sells
| 1 |
Chevron
CVX
|
+$887M |
| 2 |
Exxon Mobil
XOM
|
+$840M |
| 3 |
Meta Platforms (Facebook)
META
|
+$491M |
| 4 |
Morgan Stanley
MS
|
+$482M |
| 5 |
ConocoPhillips
COP
|
+$400M |
Sector Composition
| 1 | Technology | 27.01% |
| 2 | Financials | 14.69% |
| 3 | Healthcare | 11.43% |
| 4 | Consumer Discretionary | 9.73% |
| 5 | Industrials | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Braskem
BAK
$1.33B
| $955K | ﹤0.01% |
248,051
+9,024
| +4% | +$34.7K |
|
3252
Applied Therapeutics
APLT
$60.6M
| $954K | ﹤0.01% |
1,950,909
-115,427
| -6% | -$56.4K |
|
|
NBIS
3253
Nebius Group N.V. Class A Ordinary Shares
NBIS
$21.6B
| $949K | ﹤0.01% |
44,963
| – | – |
|
3254
Hercules Capital
HTGC
$3.53B
| $940K | ﹤0.01% |
+48,947
| New | +$940K |
|
3255
Emerald Holding
EEX
$980M
| $935K | ﹤0.01% |
237,988
-1,980
| -0.8% | -$7.78K |
|
3256
Abeona Therapeutics
ABEO
$330M
| $931K | ﹤0.01% |
195,604
+12,000
| +7% | +$57.1K |
|
3257
Purple Innovation
PRPL
$114M
| $928K | ﹤0.01% |
1,222,295
-14,761
| -1% | -$11.2K |
|
3258
Amylyx Pharmaceuticals
AMLX
$1.24B
| $927K | ﹤0.01% |
261,783
+43,400
| +20% | +$154K |
|
|
JBIO
3259
Jade Biosciences, Inc. Common Stock
JBIO
$251M
| $925K | ﹤0.01% |
10,530
-195
| -2% | -$17.1K |
|
3260
GoHealth
GOCO
$79.6M
| $925K | ﹤0.01% |
75,371
+1,700
| +2% | +$20.9K |
|
3261
Guild Holdings
GHLD
$1.24B
| $917K | ﹤0.01% |
59,930
| – | – |
|
3262
C&F Financial
CFFI
$227M
| $915K | ﹤0.01% |
13,486
+400
| +3% | +$27.1K |
|
3263
Pyxis Oncology
PYXS
$113M
| $913K | ﹤0.01% |
932,198
-11,970
| -1% | -$11.7K |
|
3264
Ramaco Resources Class B
METCB
$1.04B
| $913K | ﹤0.01% |
128,426
+18,369
| +17% | +$131K |
|
|
INZY
3265
DELISTED
Inozyme Pharma
INZY
| $907K | ﹤0.01% |
997,105
-10,350
| -1% | -$9.42K |
|
3266
Electromed
ELMD
$199M
| $907K | ﹤0.01% |
38,009
+10,578
| +39% | +$252K |
|
3267
HireQuest
HQI
$141M
| $901K | ﹤0.01% |
75,748
| – | – |
|
3268
Copel
ELP
$6.92B
| $900K | ﹤0.01% |
123,089
-15,470
| -11% | -$113K |
|
3269
RAPT Therapeutics
RAPT
$268M
| $898K | ﹤0.01% |
91,979
+4,573
| +5% | +$44.6K |
|
3270
Mersana Therapeutics
MRSN
$35.6M
| $896K | ﹤0.01% |
104,155
-6,441
| -6% | -$55.4K |
|
3271
Twin Disc
TWIN
$190M
| $892K | ﹤0.01% |
117,899
-4,981
| -4% | -$37.7K |
|
|
ORKA
3272
Oruka Therapeutics, Inc. Common Stock
ORKA
$577M
| $889K | ﹤0.01% |
86,681
+61,658
| +246% | +$633K |
|
|
CTNM
3273
Contineum Therapeutics
CTNM
$347M
| $886K | ﹤0.01% |
126,864
+2,120
| +2% | +$14.8K |
|
3274
ArcelorMittal
MT
$26.4B
| $883K | ﹤0.01% |
30,604
-1,192
| -4% | -$34.4K |
|
3275
Northern Technologies International Corp
NTIC
$73.5M
| $882K | ﹤0.01% |
84,774
| – | – |
|